Cytosponge use in risk stratification of Barrett's oesophagus

Lancet Gastroenterol Hepatol. 2017 Jan;2(1):3-4. doi: 10.1016/S2468-1253(16)30176-5. Epub 2016 Nov 11.

Authors

Liam Zakko¹, Prasad Iyer¹, Kavel Visrodia¹, Kenneth K Wang²

Affiliations

¹ Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester 55905, MN, USA.
² Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester 55905, MN, USA. Electronic address: [email protected].

PMID: 28404011
DOI: 10.1016/S2468-1253(16)30176-5

No abstract available

Publication types

Comment

MeSH terms

Barrett Esophagus*
Esophageal Neoplasms*
Humans
Risk